70799-12-1 Usage
Uses
Used in Organic Chemistry:
4-[(Dimethylamino)methyl]phenylboronic acid is used as a reagent in Suzuki-Miyaura cross-coupling reactions for the formation of carbon-carbon bonds. Its unique structure allows for the efficient formation of these bonds, which are crucial in the synthesis of complex organic molecules.
Used in Pharmaceutical Synthesis:
In the pharmaceutical industry, 4-[(Dimethylamino)methyl]phenylboronic acid is used as a key intermediate in the synthesis of various drugs. Its ability to form stable bonds with other molecules makes it a valuable component in the development of new medications.
Used in Agrochemical Synthesis:
Similarly, in the agrochemical industry, 4-[(Dimethylamino)methyl]phenylboronic acid is employed in the synthesis of agrochemicals, such as pesticides and herbicides. Its role in creating stable and effective compounds contributes to the development of more efficient and targeted agricultural products.
Used in Medicinal Chemistry and Drug Development:
Due to its potential as a ligand in catalytic processes, 4-[(Dimethylamino)methyl]phenylboronic acid is studied for its applications in medicinal chemistry. Researchers are exploring its use in the design and development of new drugs, particularly those that require specific binding properties or catalytic activity.
Check Digit Verification of cas no
The CAS Registry Mumber 70799-12-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,0,7,9 and 9 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 70799-12:
(7*7)+(6*0)+(5*7)+(4*9)+(3*9)+(2*1)+(1*2)=151
151 % 10 = 1
So 70799-12-1 is a valid CAS Registry Number.
InChI:InChI=1/C9H14BNO2/c1-11(2)7-8-3-5-9(6-4-8)10(12)13/h3-6,12-13H,7H2,1-2H3
70799-12-1Relevant academic research and scientific papers
Novel anticancer compound and usage thereof
-
Paragraph 0086; 0087; 0088; 0089, (2019/06/27)
The invention provides a novel anticancer compound. The novel anticancer compound is a compound shown in chemical formula 1 in the description or pharmaceutically acceptable salt of the compound, andthe compound and the salt are active ingredients of a pharmaceutical composition for inhibiting the activity of hepatocyte growth factor receptor (c-Met) tyrosine kinase and pharmaceutical compositionfor preventing or curing excessive or abnormal proliferative diseases. The compound effectively inhibits the activity of the hepatocyte growth factor receptor tyrosine kinase, thereby being suitablefor treating the diseases with the characteristics of excessive or abnormal cell proliferation.
Pyrrolopyrimidines and Pyrrolopyridines
-
Page/Page column 47, (2009/07/25)
Compounds of formula I in free or salt or solvate form, wherein X, T1, T3 and T4 have the meanings as indicated in the specification, are useful for treating diseases mediated by the ALK-5 and/or ALK-4 receptor. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
